2.7. CCl4‐induced liver fibrosis

HS Heidi Schilter
AF Alison D. Findlay
LP Lara Perryman
TY Tin T. Yow
JM Joshua Moses
AZ Amna Zahoor
CT Craig I. Turner
MD Mandar Deodhar
JF Jonathan S. Foot
WZ Wenbin Zhou
AG Angelique Greco
AJ Amar Joshi
BR Benjamin Rayner
ST Sarah Townsend
AB Alberto Buson
WJ Wolfgang Jarolimek
request Request a Protocol
ask Ask a question
Favorite

The study was performed by Pharmalegacy with approval from local ethics committee. Sprague Dawley rats were orally administered with 0.25 μL/g Carbon tetrachloride (CCl4) in olive oil solution, starting from day 0, 3 times per week for 6 weeks. Animals were killed 48 hours after the last CCl4 administration. PXS‐5153A was given by oral gavage after 3 weeks of CCl4 administration and continued throughout the remainder of the study at 3 mg/kg (low dose) or 10 mg/kg (high dose) once a day or 10 mg/kg (high dose) three times a week. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were assessed in the plasma. One lobe of the liver tissue was fixed in 10% formalin, stained for Sirius red and the percentage coverage area was measured. The remainder of the liver was snap frozen and used for protein, hydroxyproline and crosslink analysis.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A